MUFG Securities Americas’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$707K Buy
3,334
+290
+10% +$56.9K 0.04% 361
2026
Q1
$597K Buy
3,044
+47
+2% +$9.13K 0.04% 358
2025
Q4
$520K Sell
2,997
-19
-0.6% -$3.46K 0.03% 387
2025
Q3
$575K Buy
3,016
+542
+22% +$96.2K 0.04% 364
2025
Q2
$444K Buy
2,474
+509
+26% +$88.4K 0.04% 367
2025
Q1
$332K Buy
1,965
+317
+19% +$52.1K 0.04% 371
2024
Q4
$249K Buy
+1,648
New +$256K 0.03% 399

Other funds holding DGX

MUFG Securities Americas's DGX Position: Q2 2026 in Review

MUFG Securities Americas increased its Quest Diagnostics (DGX) stake by 9.5% in Q2 2026, buying an estimated $56.9K and bringing the position to 3,334 shares worth $707K. The position accounts for 0.04% of the portfolio, ranked #361.

MUFG Securities Americas first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • MUFG Securities Americas held 3,334 shares of Quest Diagnostics worth $707K as of Q2 2026.
  • MUFG Securities Americas bought 290 Quest Diagnostics shares in Q2 2026, an estimated $56.9K.
  • Quest Diagnostics made up 0.04% of MUFG Securities Americas's portfolio in Q2 2026, its #361 holding.
  • MUFG Securities Americas first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.